In breast cancer models, Yao et al. developed an eGFP reporter cell line based on iNOS promoter activity in RAW264.7 cells (RAW:iNos-eGFP) to monitor macrophage polarization in response to tumor-derived signals. Here, NOS2 is linked to neoplasm.